Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis of hair loss types is crucial for effective treatment.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Dextroamphetamine may help treat alopecia areata.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Oral baricitinib is effective and safe for treating alopecia areata.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

The TIP1 gene is crucial for normal plant cell growth in Arabidopsis.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Pityriasis amiantacea is linked to Staphylococcus aureus infection and can be effectively treated with antibiotics, corticosteroids, and coal tar.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib helps patients with severe alopecia areata regrow hair.